goldennet

癌精準523 (blood) / 癌必立523 (tissue) Cancer Genetic Testing

This genetic test can simultaneously diagnose 523 cancer-related genetic mutations, including somatic single nucleotide variants (SNVs), chromosomal insertions or deletions (INDELs), and fusion genes. Additionally, this assay calculates tumor mutation burden (TMB) and microsatellite instability (MSI), covering the broadest range of tumor genetic mutations recommended by the 2020 international treatment guidelines from ESMO (European Society for Medical Oncology) and the tumor biomarker testing standards from ACMG (American College of Medical Genetics and Genomics) (V3).

安可癒

This genetic test provides patients with information to determine whether their tumor contains target mutations for targeted cancer therapy or to predict treatment efficacy, through detailed output reports. The analysis process utilizes both Multiplex PCR and Next Generation Sequencing technology.

安護妳

Utilizing Multiplex PCR and Next Generation Sequencing technology, this genetic test analyzes BRCA1/2 genetic mutations, helping individuals determine whether they carry these mutations and select the most suitable treatment or prevention plan.

Down Syndrome Risk Quadruple Test 2nd Trimester Screening

During the 15th to 20th week of pregnancy, a blood sample of 5 c.c. from the mother can be used to test the serum levels of four markers (AFP, b-HCG, Inhibin A, uE3) and assess the risk of the fetus having Down syndrome

Hereditary Hearing Loss Genetic Test

Through hereditary hearing loss genetic test, one can determine whether there are mutations in the common genes associated with hereditary hearing loss. This helps to identify whether the patient is a carrier of these genes and to assess the hereditary risk of hearing loss for future offspring.